Study of Anti-HIV Therapy Intensification

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2006

Conditions

HIV Infections

Interventions

DRUG

Lopinavir/Ritonavir

DRUG

Lamivudine/Zidovudine

DRUG

Tenofovir disoproxil fumarate

BIOLOGICAL

Pneumococcal Vaccine, Polyvalent (23-valent)

DRUG

Lamivudine

DRUG

Stavudine

DRUG

Zidovudine

DRUG

Didanosine

BIOLOGICAL

Lyme Disease Vaccine Recombinant OspA

BIOLOGICAL

Haemophilus B Conjugate Vaccine

Trial Locations (3)

Case CRS, Cleveland

Rush Univ. Med. Ctr. ACTG CRS, Chicago

University of Colorado Hospital CRS, Aurora

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00034086 - Study of Anti-HIV Therapy Intensification | Biotech Hunter | Biotech Hunter